SPTA1 (Spectrin Alpha)

News alerts, weekly reports and conference planners

Entrez ID:

SPTA1 mutation	Lung Adenocarcinoma	SPTA1 mutation	Lung Adenocarcinoma	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
SPTA1 mutation + KEAP1 mutation	Lung Adenocarcinoma	SPTA1 mutation + KEAP1 mutation	Lung Adenocarcinoma	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3
EGFR exon 20 insertion + TP53 G244A + SPTA1 mutation	Non Small Cell Lung Cancer	EGFR exon 20 insertion + TP53 G244A + SPTA1 mutation	Non Small Cell Lung Cancer	cetuximab + afatinib Sensitive: C4 – Case Studies cetuximab + afatinib Sensitive : C4	cetuximab + afatinib Sensitive: C4 – Case Studies cetuximab + afatinib Sensitive : C4

Associations(3)